Stocks Endo Health Solutions Inc


  • Halftime Report: Get Long US Banks, Now?

    With the financial woes of Europe making rival US banks more attractive to investors, should you get long now?

  • Halftime Report: Trading The Market's Mixed Message

    Stocks traded sideways on Thursday as investors struggled to make sense out of this fickle market. What must you know?

  • 6 Stock Picks for 'Times Like These'

    According to the weekly survey by the American Association of Individual Investors, 49 percent of participants were still bearish. Mark Travis, CEO of Intrepid Capital Funds, and Paul Alan Davis, senior portfolio manager at Charles Schwab Investment Management, discussed what must be done to get investors off the sidelines.

  • The Lightning Round is extended in this exclusive feature.

  • Investor Spring Cleaning - A CNBC Special Report
    Build Cash and Get Short: Portfolio Manager

    Despite the market rally, portfolio manager Harry Rady of Rady Asset Management said he remains “more bearish than he’s ever been” and is continuing to take chips off the table. And Greg Olsen of Lenox Partners said he expects a pullback soon.

  • Lightning Round: Halliburton, Heinz, CSX and More

    Cramer makes the call on viewers' favorite stocks.

  • '09 Sector To Watch: Biotech

    Will M&A activity boost biotech stocks in 2009?

  • Stock Picker: Buy Black Ink

    When it comes to where investors should put their money now, Delphi Management's Scott Black is very specific.

  • Analyst: Pfizer Should Buy Amgen or Wyeth

    I thought I was finished with the post-Pfizer analyst meeting reaction with yesterday's post, but when an extraordinarily bearish 77-page research note from Credit Suisse big pharma analyst Catherine Arnold arrived in my inbox this morning, I had to do one more installment. She thinks Pfizer should buy Wyeth or Amgen...

  • Nancy Beaumont
    Finals Contest: Nancy Beaumont Takes Top Spot

    Good morning. Chinese gaming stocks are in the spotlight Monday as The9 propelled Nancy Beaumont to the top of the pack on its 10.31% gain. The9 was up on the news that Electronic Arts agreed to buy a $167M stake in the company, and also licensed a soccer game to The9. Steven Lee managed to hold onto second even though he was all in cash after Friday's trading. He has now gone all-in on Neurochem.